[{"NetIncomeLoss_1_Q3_USD":-21403000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":30381671.0,"CommitmentsAndContingencies_0_Q3_USD":null,"WeightedAverageNumberOfSharesRestrictedStock_1_Q3_shares":53679.0,"WeightedAverageNumberOfSharesRestrictedStock_3_Q3_shares":41938.0,"OperatingCostsAndExpenses_1_Q3_USD":21538000.0,"OperatingCostsAndExpenses_3_Q3_USD":50371000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":16000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":68735000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-27660000.0,"Depreciation_3_Q3_USD":6000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":202554000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q3_shares":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":34002769.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":194500.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":321000.0,"AssetsCurrent_0_Q3_USD":298033000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":3207143.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":163000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":1546000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":312000.0,"AvailableForSaleDebtSecuritiesGrossUnrealizedGain_3_Q3_USD":16000.0,"CommonStockSharesIssued_0_Q3_shares":34720675.0,"UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_0_Q3_USD":14171000.0,"Assets_0_Q3_USD":300036000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q3_USD":9.03,"ShareBasedCompensation_3_Q3_USD":4106000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1710000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_3_Q3_USD":0.0,"GeneralAndAdministrativeExpense_3_Q3_USD":11164000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":4159000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":7.63,"ResearchAndDevelopmentExpense_1_Q3_USD":17379000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":39207000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":9.03,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":2242000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":-1183000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":135000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":875000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_Q3_pure":0.0581,"CommonStockValue_0_Q3_USD":4000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_1_Q3_USD":9000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":203048000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_3_Q3_USD":0.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":291870000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_3_Q3_USD":0.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-21477000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-49474000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":3689000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3_Q3_pure":0.777,"OtherAssetsNoncurrent_0_Q3_USD":156000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":192679000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":1564000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":466254000.0,"Liabilities_0_Q3_USD":13578000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q3_shares":48501.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":-2000.0,"OperatingLeaseLiability_0_Q3_USD":1741000.0,"MarketableSecuritiesCurrent_0_Q3_USD":99191000.0,"CommonStockDividendsPerShareDeclared_3_Q3_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":0.61,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":202554000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":14.76,"LeaseCost_1_Q3_USD":81000.0,"MarketableSecurities_0_Q3_USD":239230000.0,"CommonStockSharesOutstanding_0_Q3_shares":34720675.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":106041000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":3158642.0,"MarketableSecuritiesUnrealizedGainLoss_3_Q3_USD":22000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q3_USD":-74000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-47409000.0,"CommonStockDividendsPerShareCashPaid_3_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":303000.0,"LiabilitiesCurrent_0_Q3_USD":12014000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":127979000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q3_USD":68735000.0,"AccountsPayableCurrent_0_Q3_USD":4636000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":192827000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":6163000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":284000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3_Q3_USD":0.48,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.076,"CashEquivalentsAtCarryingValue_0_Q3_USD":140039000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3_Q3_shares":106648.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":131193.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_3_Q3_USD":0.0,"OperatingLeasePayments_3_Q3_USD":135000.0,"OperatingLeasePayments_1_Q3_USD":18000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":19383000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":137000.0,"NetIncomeLoss_3_Q3_USD":-49496000.0,"LeaseCost_3_Q3_USD":261000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":75000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-179816000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":3158642.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":501000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":331000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":4539000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"OperatingIncomeLoss_3_Q3_USD":-50371000.0,"OperatingIncomeLoss_1_Q3_USD":-21538000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q3_shares":6425793.0,"DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0_Q3_USD":239214000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":239230000.0,"InvestmentIncomeInterest_3_Q3_USD":875000.0,"InvestmentIncomeInterest_1_Q3_USD":135000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0107,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":22.45,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":2.16,"LiabilitiesAndStockholdersEquity_0_Q3_USD":300036000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":1442000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":4106000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":1546000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":14470000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":1220.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":177000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":1751000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.63,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.63,"ProfitLoss_3_Q3_USD":-49496000.0,"StockholdersEquity_0_Q3_USD":286458000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":143000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":41000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":836701.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":474000.0,"Ticker":"AKRO","CIK":"1744659","name":"AKERO THERAPEUTICS, INC.","OfficialName":"Akero Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"399847718.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201112"}]